Piramal Pharma swings to ₹5 crore profit in Q2 as revenue rises 28%

SENSEX 73,598.67

 -8.08

NIFTY 22,749.75

 -3.45

CRUDEOIL 9,501.00

 -222.00

GOLD 144,100.00

+ 1,027.00

SILVER 196,750.00

+ 957.00

SENSEX 73,598.67

 -8.08

NIFTY 22,749.75

 -3.45

NIFTY 22,749.75

 -3.45

CRUDEOIL 9,501.00

 -222.00

CRUDEOIL 9,501.00

 -222.00

GOLD 144,100.00

+ 1,027.00

'; } document.getElementById("lgdv").innerHTML = htmlElements; } function numberformat(i) { return Number(parseFloat(i).toFixed(2)).toLocaleString('en', { minimumFractionDigits: 2 }) } async function gatherResponse(response) { const { headers } = response; const contentType = headers.get('content-type') || ''; if (contentType.includes('application/json')) { return await response.json() } return response.text(); } function getWidth() { if (Math.max(document.body.scrollWidth,document.documentElement.scrollWidth,document.body.offsetWidth,document.documentElement.offsetWidth,document.documentElement.clientWidth) > 991) { document.getElementById("mob").style.display = "none"; document.getElementById("lgdv").style.display = "block"; } else { document.getElementById("mob").style.display = "block"; document.getElementById("lgdv").style.display = "none"; } } getWidth(); THIS AD SUPPORTS OUR JOURNALISM. SUBSCRIBE FOR MINIMAL ADS.THIS AD SUPPORTS OUR JOURNALISM. SUBSCRIBE FOR MINIMAL ADS.

The Mumbai-based pharmaceutical company recorded higher operating revenue during the quarter, while its total expenses also increased year-on-year

By PTI

Updated - October 28, 2026 at 12:49 AM. | New Delhi

Piramal Pharma reported a consolidated net profit of ₹5 crore in the July-September quarter as revenue from operations increased year-on-year.

Piramal Pharma on Thursday reported a consolidated net profit of Rs 5 crore in the July-September period of the current fiscal year.

The pharma company had posted a loss of Rs 99.22 crore in the year-ago period, the company said in a regulatory filing on Tuesday evening.

Revenue from operations rose to Rs 2,617.06 crore in the second quarter of the ongoing fiscal year, up from Rs 2,043.72 crore in the year-ago period, the Mumbai-based firm said.

Its total expenses, too, grew to Rs 2,589.10 crore in the September quarter from Rs 2,170.29 crore in the corresponding period of the previous year.

Piramal Pharma shares settled 1.69 per cent higher at 198.45 apiece on the BSE.

Published on October 28, 2026

THIS AD SUPPORTS OUR JOURNALISM. SUBSCRIBE FOR MINIMAL ADS. THIS AD SUPPORTS OUR JOURNALISM. SUBSCRIBE FOR MINIMAL ADS. THIS AD SUPPORTS OUR JOURNALISM. SUBSCRIBE FOR MINIMAL ADS. THIS AD SUPPORTS OUR JOURNALISM. SUBSCRIBE FOR MINIMAL ADS.Sign into Unlock benefits!

• Access 10 free stories per month
• Get notified by email for early preview to new features, discounts & offers